Teneligliptin hydrobromide

• Target:

  Interleukin|||ROS|||DPP-4|||NF-?B|||Proteasome|||p38 MAPK|||Apoptosis|||AMPK|||JNK|||NOD-like Receptor (NLR) |||Immunology/Inflammation related

• Related Pathways:

  Proteases/Proteasome|||Chromatin/Epigenetic|||NF-?B|||PI3K/Akt/mTOR signaling|||Immunology/Inflammation|||Ubiquitination|||MAPK|||Apoptosis

• Purity:

  >99.99%

• Bioactivity:

  Teneligliptin hydrobromide (MP-513 (hydrobromide) ) is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor; competitively inhibited human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50 values of approximately 1 nM.

• Smiles:

  Br.Br.Br.Br.Br.Cc1cc(N2CCN(CC2)C2CNC(C2)C(=O)N2CCSC2)n(n1)-c1ccccc1.Cc1cc(N2CCN(CC2)C2CNC(C2)C(=O)N2CCSC2)n(n1)-c1ccccc1

• Molecular Formula:

  C22H30N6OS·5/2BrH

• Molecular Weight:

  628.86

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  906093-29-6